Alethia Young's most recent trade in Bicycle Therapeutics Plc - ADR was a trade of 204 Ordinary Shares done at an average price of $7.1 . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bicycle Therapeutics Plc -... | Alethia Young | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.09 per share. | 02 Jul 2025 | 204 | 45,186 | - | 7.1 | 1,446 | Ordinary Shares |
| Pacira BioSciences Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,279 | 11,279 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,163 | 11,393 (0%) | 0% | 0 | Common Stock | |
| Bicycle Therapeutics Plc -... | Alethia Young | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.02 per share. | 02 Apr 2025 | 215 | 45,390 | - | 8.0 | 1,724 | Ordinary Shares |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 8,800 | 8,800 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 4,000 | 17,067 (0%) | 0% | 0 | Common Stock | |
| Bicycle Therapeutics Plc -... | Alethia Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 87,000 | 87,000 | - | - | Employee Stock Option (right to buy) | |
| Bicycle Therapeutics Plc -... | Alethia Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 35,000 | 47,000 | - | 0 | Ordinary Shares | |
| Bicycle Therapeutics Plc -... | Alethia Young | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.09 per share. | 02 Jan 2025 | 1,395 | 45,605 | - | 14.1 | 19,656 | Ordinary Shares |
| Pacira BioSciences Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,179 | 12,179 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 5,230 | 5,230 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Young Alethia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Young Alethia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 4,000 | 13,067 (0%) | 0% | 0 | Common Stock | |
| Bicycle Therapeutics Plc -... | Alethia Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 24,000 | 24,000 | - | - | Employee Stock Option (right to buy) | |
| Bicycle Therapeutics Plc -... | Alethia Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 12,000 | 12,000 | - | 0 | Ordinary Shares | |
| Graphite Bio Inc | Alethia Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 220,000 | 220,000 | - | - | Stock Option (right to buy) | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 4,000 | 9,067 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 7,000 | 7,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 3,200 | 3,200 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 1,867 | 5,067 (0%) | 0% | 0 | Common Stock | |
| Graphite Bio Inc | Alethia Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 350,000 | 350,000 | - | - | Stock Option (right to buy) |